Walleye Trading
KURA icon

Walleye Trading’s Kura Oncology KURA Stock Holding History

Walleye Trading’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,055
Closed -$73.3K – 4427
2025
Q4 		$73.3K Buy
+7,055
New +$74K ﹤0.01% 3846
2024
Q3 		– Sell
-747
Closed -$15.4K – 4367
2024
Q2 		$15.4K Sell
747
-8,941
-92% -$184K ﹤0.01% 3809
2024
Q1 		$207K Buy
+9,688
New +$188K ﹤0.01% 3398
2022
Q4 		– Sell
-33,220
Closed -$454K – 5192
2022
Q3 		$454K Buy
+33,220
New +$512K ﹤0.01% 2988
2018
Q4 		– Sell
-95,140
Closed -$1.67M – 4992
2018
Q3 		$1.67M Sell
95,140
-28,389
-23% -$544K 0.01% 1518
2018
Q2 		$2.25M Buy
123,529
+29,397
+31% +$498K 0.01% 1221
2018
Q1 		$1.76M Buy
+94,132
New +$1.83M 0.01% 1322

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's KURA Position: Q1 2026 in Review

Walleye Trading sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 7,055 shares — an estimated $73.3K sold.

Walleye Trading first reported a position in KURA in Q1 2018 and held it in 7 quarters. The position peaked at $2.25M in Q2 2018. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Walleye Trading reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 7,055 Kura Oncology shares in Q1 2026, an estimated $73.3K.
  • Walleye Trading first reported a position in Kura Oncology in Q1 2018 and held it in 7 quarters.
  • Walleye Trading's Kura Oncology position peaked at $2.25M in Q2 2018.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.